North America Renal Denervation Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 3.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Renal Denervation Devices Market Analysis
North America Renal Denervation Devices Market is expected to register a CAGR of 3% during the forecast period. The major factors responsible for the growth of the renal denervation devices market include the rising prevalence of hypertension and the long-lasting effect of the procedure.
High blood pressure is called hypertension. The prevalence of hypertension has been observing a significant rise, over the past few years in North American Countries. Generally, blood pressure rises and falls throughout the day, but it can damage one's heart and result in health problems if hypertension stays high for a long time.
According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of them, with high blood pressure, have their condition under control. High blood pressure had been the primary contributing cause of death for more than 410,000 Americans, in 2014. CDC also stated that high blood pressure costs the country USD 48.6 billion, every year. The high prevalence is not just limited to the United State, owing to the fact that the Canada and Mexico also have a high rate of hypertension.
Thus, owing to all of the aforementioned factors, the market studied is expected to witness high growth, in the coming years.
North America Renal Denervation Devices Market Trends
This section covers the major market trends shaping the North America Renal Denervation Devices Market according to our research experts:
The Ultrasound-based Segment is Expected to be the Fastest Growing Segment
· The ultrasound-based renal denervation devices are a minimally invasive procedure, using ultrasound to ablate nerves in the wall of the renal arteries, and it disrupts the transmission of nerve impulses to and from the kidney and lowers blood pressure. Additionally, according to the first randomized trial to compare the techniques (RADIOSOUND-HTN trial), the ultrasound-based renal denervation (RDN) approach has led to greater reductions in blood pressure than radiofrequency ablation in patients, with resistant hypertension. The rising prevalence of hypertension is expected to boost the overall growth of the market studied.
· COVID-19 has negatively impacted the number of procedures and the production of the devices in North America. Due to the fear of transmission of the virus, many hospitals have canceled the procedures and the manufacturing and supply chain was disturbed due to the lockdown worldwide. Additionally, many trials and product approvals have been pending for the year, which is impacting market growth.
North America Renal Denervation Devices Industry Overview
The North America Renal Denervation Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Medtronic PLC, St. Jude Medical Inc., ReCor Medical Inc., Ablative Solutions Inc., Mercator MedSystems, Terumo Corporation, Symple Surgical.
North America Renal Denervation Devices Market Leaders
-
Medtronic PLC
-
St. Jude Medical Inc.
-
ReCor Medical Inc
-
Ablative Solutions Inc
-
Mercator MedSystems
*Disclaimer: Major Players sorted in no particular order
North America Renal Denervation Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Hypertension
- 4.2.2 Long Lasting Effect of the Procedure
-
4.3 Market Restraints
- 4.3.1 Painful Procedure
- 4.3.2 Stringent Approval Process for Renal Denervation Devices and Reimbursement Systems
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Technology
- 5.1.1 Radiofrequency-based
- 5.1.2 Ultrasound-based
- 5.1.3 Micro-infusion-based
-
5.2 Geography
- 5.2.1 North America
- 5.2.1.1 United States
- 5.2.1.2 Canada
- 5.2.1.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medtronic PLC
- 6.1.2 St. Jude Medical Inc.
- 6.1.3 ReCor Medical Inc.
- 6.1.4 Ablative Solutions Inc.
- 6.1.5 Mercator MedSystems
- 6.1.6 Terumo Corporation
- 6.1.7 Symple Surgical
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Renal Denervation Devices Industry Segmentation
As per the scope of this report, renal denervation devices are one of several innovative device-based interventional therapies, which help to control blood pressure. It is safe, minimally invasive, and does not leave any implants behind. The market studied is segmented by technology and geography.
| By Technology | Radiofrequency-based | |
| Ultrasound-based | ||
| Micro-infusion-based | ||
| Geography | North America | United States |
| Canada | ||
| Mexico |
North America Renal Denervation Devices Market Research FAQs
What is the current North America Renal Denervation Devices Market size?
The North America Renal Denervation Devices Market is projected to register a CAGR of 3% during the forecast period (2024-2029)
Who are the key players in North America Renal Denervation Devices Market?
Medtronic PLC, St. Jude Medical Inc. , ReCor Medical Inc, Ablative Solutions Inc and Mercator MedSystems are the major companies operating in the North America Renal Denervation Devices Market.
What years does this North America Renal Denervation Devices Market cover?
The report covers the North America Renal Denervation Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Renal Denervation Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Renal Denervation Devices Industry Report
Statistics for the 2024 North America Renal Denervation Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Renal Denervation Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
